| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | CDH23 CRACR2B ADGRV1 PLA2G4D RYR1 IQGAP1 UMODL1 MMP13 PCDHB1 SLC25A23 NID2 FAT4 PCDHGB7 PCDHGB2 PCDHGA11 PCDHGA2 ANXA13 NUCB1 PPEF1 DNAH7 PCDHB16 CELSR1 PLA2G4C TLL2 DCHS1 LRP4 RASEF UNC13C PCDH8 | 1.55e-08 | 749 | 233 | 29 | GO:0005509 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCC3 LRRK2 MCM6 ABCA9 KIF3B HRAS KIF3C DNAH8 KRAS DDX31 NRAS DHX57 ATP10A DNAH7 ATP8B2 ATL1 KIF3A DNAH12 SLFN13 RRAGA EIF5B RASEF DHX34 XRCC6 AQR | 4.51e-06 | 775 | 233 | 25 | GO:0017111 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.02e-05 | 118 | 233 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC3 MYH13 MCM6 ABCA9 KIF3B KIF3C DNAH8 APPBP2 DDX31 SAE1 DHX57 MSH4 ATP10A DNAH7 ATP8B2 KIF3A DNAH12 SLFN13 DHX34 XRCC6 AQR | 1.14e-05 | 614 | 233 | 21 | GO:0140657 |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 1.32e-05 | 45 | 233 | 6 | GO:0043495 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.73e-05 | 70 | 233 | 7 | GO:0003777 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCC3 LRRK2 MCM6 ABCA9 KIF3B HRAS KIF3C DNAH8 KRAS DDX31 NRAS DHX57 ATP10A DNAH7 ATP8B2 ATL1 KIF3A DNAH12 SLFN13 RRAGA EIF5B RASEF DHX34 XRCC6 AQR | 1.75e-05 | 839 | 233 | 25 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCC3 LRRK2 MCM6 ABCA9 KIF3B HRAS KIF3C DNAH8 KRAS DDX31 NRAS DHX57 ATP10A DNAH7 ATP8B2 ATL1 KIF3A DNAH12 SLFN13 RRAGA EIF5B RASEF DHX34 XRCC6 AQR | 1.78e-05 | 840 | 233 | 25 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCC3 LRRK2 MCM6 ABCA9 KIF3B HRAS KIF3C DNAH8 KRAS DDX31 NRAS DHX57 ATP10A DNAH7 ATP8B2 ATL1 KIF3A DNAH12 SLFN13 RRAGA EIF5B RASEF DHX34 XRCC6 AQR | 1.78e-05 | 840 | 233 | 25 | GO:0016818 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC3 MCM6 ABCA9 KIF3B KIF3C DNAH8 DDX31 DHX57 ATP10A DNAH7 ATP8B2 KIF3A DNAH12 SLFN13 DHX34 XRCC6 AQR | 1.80e-05 | 441 | 233 | 17 | GO:0016887 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPR PHACTR2 MYH13 NDE1 SPTB LRRK2 GAS8 ADGRV1 IQGAP1 KIF3B NDRG1 KCNA5 SYNE2 KIF3C PLEC USH2A APPBP2 KLHL1 FNTA NUMA1 SHROOM2 PFN3 KIF3A SPTBN4 CEP70 MYO16 | 4.96e-04 | 1099 | 233 | 26 | GO:0008092 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CHL1 CDH23 PKD1 PCDHB1 FAT4 SDK2 PCDHGB7 PCDHGB2 PCDHGA11 PCDHGA2 PCDHB16 CELSR1 DCHS1 PCDH8 | 2.51e-08 | 187 | 230 | 14 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CHL1 CDH23 PKD1 PCDHB1 FAT4 SDK2 PCDHGB7 PCDHGB2 PCDHGA11 PCDHGA2 PCDHB16 CELSR1 DCHS1 IL1RAP PCDH8 | 2.55e-06 | 313 | 230 | 15 | GO:0098742 |
| GeneOntologyCellularComponent | microtubule associated complex | 1.31e-05 | 161 | 232 | 10 | GO:0005875 | |
| GeneOntologyCellularComponent | cytoplasmic region | LRRK2 GAS8 DNAJB13 KIF3B KIF3C DNAH8 CNTRL NUMA1 DNAH7 KIF3A RSPH3 DNAH12 UNC13C | 2.06e-04 | 360 | 232 | 13 | GO:0099568 |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 2.85e-04 | 114 | 232 | 7 | GO:0005798 | |
| GeneOntologyCellularComponent | supramolecular fiber | EPPK1 MYH13 NDE1 GAS8 RYR1 KRT73 IQGAP1 KIF3B NDRG1 KCNA5 SYNE2 SIMC1 KIF3C PLEC DNAH8 COL1A1 APPBP2 NUMA1 KRT87P KRT79 SHROOM2 DNAH7 KIF3A SPTBN4 NARF DNAH12 RTL1 | 2.93e-04 | 1179 | 232 | 27 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | EPPK1 MYH13 NDE1 GAS8 RYR1 KRT73 IQGAP1 KIF3B NDRG1 KCNA5 SYNE2 SIMC1 KIF3C PLEC DNAH8 COL1A1 APPBP2 NUMA1 KRT87P KRT79 SHROOM2 DNAH7 KIF3A SPTBN4 NARF DNAH12 RTL1 | 3.26e-04 | 1187 | 232 | 27 | GO:0099081 |
| GeneOntologyCellularComponent | nuclear speck | SART3 CHRNA3 CRNKL1 SCAPER ASCC2 KAZN SMURF2 RBM11 RBM4B RBM4 PATL1 SIRT7 PRPF8 SART1 | 3.48e-04 | 431 | 232 | 14 | GO:0016607 |
| GeneOntologyCellularComponent | kinesin II complex | 3.65e-04 | 3 | 232 | 2 | GO:0016939 | |
| HumanPheno | Linear nevus sebaceous | 2.60e-06 | 3 | 71 | 3 | HP:0010817 | |
| HumanPheno | Nevus sebaceous | 2.54e-05 | 5 | 71 | 3 | HP:0010815 | |
| Domain | Cadherin_CS | CDH23 PCDHB1 FAT4 PCDHGB7 PCDHGB2 PCDHGA11 PCDHGA2 PCDHB16 CELSR1 DCHS1 PCDH8 | 8.66e-08 | 109 | 226 | 11 | IPR020894 |
| Domain | CADHERIN_1 | CDH23 PCDHB1 FAT4 PCDHGB7 PCDHGB2 PCDHGA11 PCDHGA2 PCDHB16 CELSR1 DCHS1 PCDH8 | 1.26e-07 | 113 | 226 | 11 | PS00232 |
| Domain | Cadherin | CDH23 PCDHB1 FAT4 PCDHGB7 PCDHGB2 PCDHGA11 PCDHGA2 PCDHB16 CELSR1 DCHS1 PCDH8 | 1.26e-07 | 113 | 226 | 11 | PF00028 |
| Domain | CADHERIN_2 | CDH23 PCDHB1 FAT4 PCDHGB7 PCDHGB2 PCDHGA11 PCDHGA2 PCDHB16 CELSR1 DCHS1 PCDH8 | 1.38e-07 | 114 | 226 | 11 | PS50268 |
| Domain | - | CDH23 PCDHB1 FAT4 PCDHGB7 PCDHGB2 PCDHGA11 PCDHGA2 PCDHB16 CELSR1 DCHS1 PCDH8 | 1.38e-07 | 114 | 226 | 11 | 2.60.40.60 |
| Domain | CA | CDH23 PCDHB1 FAT4 PCDHGB7 PCDHGB2 PCDHGA11 PCDHGA2 PCDHB16 CELSR1 DCHS1 PCDH8 | 1.51e-07 | 115 | 226 | 11 | SM00112 |
| Domain | Cadherin-like | CDH23 PCDHB1 FAT4 PCDHGB7 PCDHGB2 PCDHGA11 PCDHGA2 PCDHB16 CELSR1 DCHS1 PCDH8 | 1.65e-07 | 116 | 226 | 11 | IPR015919 |
| Domain | Cadherin | CDH23 PCDHB1 FAT4 PCDHGB7 PCDHGB2 PCDHGA11 PCDHGA2 PCDHB16 CELSR1 DCHS1 PCDH8 | 1.96e-07 | 118 | 226 | 11 | IPR002126 |
| Domain | Spectrin_repeat | 1.11e-06 | 29 | 226 | 6 | IPR002017 | |
| Domain | P-loop_NTPase | ABCC3 MYH13 LRRK2 MCM6 ABCA9 IQGAP1 LRGUK KIF3B HRAS KIF3C DNAH8 KRAS DDX31 NRAS DHX57 MSH4 LRRK1 DNAH7 ATL1 KIF3A DNAH12 SLFN13 RRAGA EIF5B RASEF DHX34 MYO16 AQR | 1.44e-06 | 848 | 226 | 28 | IPR027417 |
| Domain | SPEC | 2.05e-06 | 32 | 226 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.05e-06 | 32 | 226 | 6 | IPR018159 | |
| Domain | Spectrin | 6.99e-06 | 23 | 226 | 5 | PF00435 | |
| Domain | Cadherin_C | 1.07e-05 | 42 | 226 | 6 | IPR032455 | |
| Domain | Cadherin_C_2 | 1.07e-05 | 42 | 226 | 6 | PF16492 | |
| Domain | Cadherin_2 | 1.33e-05 | 65 | 226 | 7 | PF08266 | |
| Domain | Cadherin_N | 1.33e-05 | 65 | 226 | 7 | IPR013164 | |
| Domain | - | ABCC3 LRRK2 MCM6 ABCA9 LRGUK HRAS DNAH8 KRAS DDX31 NRAS DHX57 MSH4 LRRK1 DNAH7 ATL1 DNAH12 SLFN13 RRAGA EIF5B RASEF DHX34 AQR | 1.11e-04 | 746 | 226 | 22 | 3.40.50.300 |
| Domain | COR | 1.46e-04 | 2 | 226 | 2 | IPR032171 | |
| Domain | COR | 1.46e-04 | 2 | 226 | 2 | PF16095 | |
| Domain | ACTININ_2 | 1.54e-04 | 23 | 226 | 4 | PS00020 | |
| Domain | ACTININ_1 | 1.54e-04 | 23 | 226 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.54e-04 | 23 | 226 | 4 | IPR001589 | |
| Domain | HAT | 1.97e-04 | 10 | 226 | 3 | SM00386 | |
| Domain | HAT | 1.97e-04 | 10 | 226 | 3 | IPR003107 | |
| Domain | USP7_C2 | 4.34e-04 | 3 | 226 | 2 | PF14533 | |
| Domain | USP_C | 4.34e-04 | 3 | 226 | 2 | IPR029346 | |
| Domain | MHD | 4.57e-04 | 13 | 226 | 3 | PS51072 | |
| Domain | MHD | 4.57e-04 | 13 | 226 | 3 | IPR028565 | |
| Domain | TPR-contain_dom | 4.90e-04 | 150 | 226 | 8 | IPR013026 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.77e-04 | 14 | 226 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 5.77e-04 | 14 | 226 | 3 | IPR013602 | |
| Domain | DHC_N2 | 5.77e-04 | 14 | 226 | 3 | PF08393 | |
| Domain | AAA_8 | 5.77e-04 | 14 | 226 | 3 | PF12780 | |
| Domain | DHC_fam | 7.14e-04 | 15 | 226 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 7.14e-04 | 15 | 226 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 7.14e-04 | 15 | 226 | 3 | IPR004273 | |
| Domain | Ubiquitin_3 | 8.61e-04 | 4 | 226 | 2 | PF14836 | |
| Domain | Ub_USP-typ | 8.61e-04 | 4 | 226 | 2 | IPR028135 | |
| Domain | ROC_dom | 8.61e-04 | 4 | 226 | 2 | IPR020859 | |
| Domain | Spectrin_bsu | 8.61e-04 | 4 | 226 | 2 | IPR016343 | |
| Domain | ROC | 8.61e-04 | 4 | 226 | 2 | PS51424 | |
| Domain | Cadherin_tail | 1.01e-03 | 37 | 226 | 4 | PF15974 | |
| Domain | Cadherin_CBD | 1.01e-03 | 37 | 226 | 4 | IPR031904 | |
| Domain | LAM_G_DOMAIN | 1.12e-03 | 38 | 226 | 4 | PS50025 | |
| Domain | CH | 1.14e-03 | 65 | 226 | 5 | SM00033 | |
| Domain | Laminin_G_2 | 1.36e-03 | 40 | 226 | 4 | PF02210 | |
| Domain | CH | 1.59e-03 | 70 | 226 | 5 | PF00307 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 5.84e-06 | 22 | 173 | 5 | M26929 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2 | 6.76e-06 | 11 | 173 | 4 | M29814 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_IN_CANCER | 1.40e-05 | 26 | 173 | 5 | M29535 | |
| Pathway | REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS | 1.78e-05 | 5 | 173 | 3 | M26921 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | 1.99e-05 | 14 | 173 | 4 | M569 | |
| Pathway | REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ | 3.54e-05 | 6 | 173 | 3 | M27951 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY | 3.54e-05 | 6 | 173 | 3 | M47433 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX | 3.54e-05 | 6 | 173 | 3 | M47931 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1 | 3.54e-05 | 6 | 173 | 3 | M47932 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 3.55e-05 | 16 | 173 | 4 | M562 | |
| Pathway | REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS | 6.13e-05 | 7 | 173 | 3 | M29717 | |
| Pathway | REACTOME_SOS_MEDIATED_SIGNALLING | 6.13e-05 | 7 | 173 | 3 | M19489 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY | 7.35e-05 | 19 | 173 | 4 | M47793 | |
| Pathway | REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS | 9.72e-05 | 8 | 173 | 3 | M27919 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP | 9.72e-05 | 8 | 173 | 3 | M47935 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY | 1.11e-04 | 21 | 173 | 4 | M47792 | |
| Pathway | REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN | 1.45e-04 | 9 | 173 | 3 | M27156 | |
| Pathway | REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R | 1.45e-04 | 9 | 173 | 3 | M27173 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS | 1.45e-04 | 9 | 173 | 3 | M27904 | |
| Pathway | KEGG_MEDICUS_REFERENCE_E2_ER_RAS_ERK_SIGNALING_PATHWAY | 1.62e-04 | 23 | 173 | 4 | M47799 | |
| Pathway | REACTOME_RAS_PROCESSING | 1.92e-04 | 24 | 173 | 4 | M38995 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 2.40e-04 | 46 | 173 | 5 | M39828 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 2.66e-04 | 47 | 173 | 5 | M646 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE | 2.79e-04 | 11 | 173 | 3 | M27535 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 2.79e-04 | 11 | 173 | 3 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 2.79e-04 | 11 | 173 | 3 | M47371 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 2.79e-04 | 11 | 173 | 3 | MM14760 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3 | 2.79e-04 | 11 | 173 | 3 | M27911 | |
| Pathway | REACTOME_MET_ACTIVATES_RAS_SIGNALING | 2.79e-04 | 11 | 173 | 3 | M27740 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY | 2.79e-04 | 11 | 173 | 3 | M47436 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY | 2.79e-04 | 11 | 173 | 3 | M47432 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | 2.79e-04 | 11 | 173 | 3 | MM14533 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 3.56e-04 | 50 | 173 | 5 | M553 | |
| Pathway | WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING | 3.56e-04 | 28 | 173 | 4 | M39572 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 3.68e-04 | 12 | 173 | 3 | M47369 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 3.68e-04 | 12 | 173 | 3 | M47815 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS | 3.68e-04 | 12 | 173 | 3 | M29851 | |
| Pathway | WP_RALA_DOWNSTREAM_REGULATED_GENES | 3.68e-04 | 12 | 173 | 3 | M39408 | |
| Pathway | KEGG_THYROID_CANCER | 4.09e-04 | 29 | 173 | 4 | M523 | |
| Pathway | REACTOME_SIGNALING_BY_EGFR | 4.68e-04 | 53 | 173 | 5 | M27039 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 4.75e-04 | 13 | 173 | 3 | M47594 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 4.75e-04 | 13 | 173 | 3 | M1441 | |
| Pathway | REACTOME_SIGNALING_BY_PTK6 | 5.11e-04 | 54 | 173 | 5 | M29742 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 5.99e-04 | 14 | 173 | 3 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 5.99e-04 | 14 | 173 | 3 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 5.99e-04 | 14 | 173 | 3 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 5.99e-04 | 14 | 173 | 3 | M47390 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 5.99e-04 | 14 | 173 | 3 | M47378 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS | 5.99e-04 | 14 | 173 | 3 | M27908 | |
| Pathway | REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES | 5.99e-04 | 14 | 173 | 3 | M27734 | |
| Pathway | PID_TCR_RAS_PATHWAY | 5.99e-04 | 14 | 173 | 3 | M134 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 5.99e-04 | 14 | 173 | 3 | M47488 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 5.99e-04 | 14 | 173 | 3 | M719 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII | 7.41e-04 | 15 | 173 | 3 | M29701 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 7.41e-04 | 15 | 173 | 3 | M47367 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 7.41e-04 | 15 | 173 | 3 | M47389 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 7.41e-04 | 15 | 173 | 3 | M47375 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 7.41e-04 | 15 | 173 | 3 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 7.41e-04 | 15 | 173 | 3 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 7.41e-04 | 15 | 173 | 3 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 7.41e-04 | 15 | 173 | 3 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 7.41e-04 | 15 | 173 | 3 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 7.41e-04 | 15 | 173 | 3 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 7.41e-04 | 15 | 173 | 3 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 7.41e-04 | 15 | 173 | 3 | M47475 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 7.41e-04 | 15 | 173 | 3 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 7.41e-04 | 15 | 173 | 3 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 7.41e-04 | 15 | 173 | 3 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 7.41e-04 | 15 | 173 | 3 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 7.41e-04 | 15 | 173 | 3 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 7.41e-04 | 15 | 173 | 3 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 7.41e-04 | 15 | 173 | 3 | M47531 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.04e-04 | 16 | 173 | 3 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 9.04e-04 | 16 | 173 | 3 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 9.04e-04 | 16 | 173 | 3 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 9.04e-04 | 16 | 173 | 3 | M47804 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY | 9.04e-04 | 16 | 173 | 3 | M47801 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 9.04e-04 | 16 | 173 | 3 | M41733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY | 9.04e-04 | 16 | 173 | 3 | M47682 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS | 9.04e-04 | 16 | 173 | 3 | M29847 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 9.04e-04 | 16 | 173 | 3 | M47483 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.04e-03 | 63 | 173 | 5 | M11187 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 1.09e-03 | 17 | 173 | 3 | M47376 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY | 1.09e-03 | 17 | 173 | 3 | M47684 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK3_TRKC | 1.09e-03 | 17 | 173 | 3 | M27918 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE | 1.17e-03 | 38 | 173 | 4 | M27536 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.17e-03 | 38 | 173 | 4 | MM14969 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 1.29e-03 | 18 | 173 | 3 | M27518 | |
| Pathway | WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS | 1.29e-03 | 18 | 173 | 3 | M39737 | |
| Pathway | REACTOME_TIE2_SIGNALING | 1.29e-03 | 18 | 173 | 3 | M11932 | |
| Pathway | REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK | 1.29e-03 | 18 | 173 | 3 | M657 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 1.42e-03 | 40 | 173 | 4 | M27557 | |
| Pathway | PID_EPHB_FWD_PATHWAY | 1.42e-03 | 40 | 173 | 4 | M62 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS | 1.52e-03 | 19 | 173 | 3 | M559 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 1.52e-03 | 19 | 173 | 3 | M27423 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 1.52e-03 | 19 | 173 | 3 | M41732 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR3_SIGNALING | 1.78e-03 | 20 | 173 | 3 | M27519 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR4 | 1.78e-03 | 20 | 173 | 3 | M27524 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 1.78e-03 | 20 | 173 | 3 | M17670 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 1.78e-03 | 20 | 173 | 3 | M39002 | |
| Pubmed | UTP6 SART3 TPR EPPK1 USP11 MCM6 NDUFS1 IQGAP1 CRNKL1 SYNE2 MKI67 PLEC DDX31 NUP107 UBR4 NUMA1 DHX57 COPG2 SIRT7 PRPF8 SART1 SEC24C ASNS EIF5B PRKDC LAS1L XRCC6 AQR HERC5 | 1.35e-15 | 653 | 235 | 29 | 22586326 | |
| Pubmed | SART3 PHACTR2 MYH13 ADAM7 PLA2G4D NDUFS1 KRT73 IQGAP1 UMODL1 SYNE2 VPS13A ALDH1A1 PLEC DNAH8 SMURF2 PCDHGB7 PCDHGB2 PCDHGA11 PCDHGA2 CNTRL UBR4 NUCB1 NUMA1 DHX57 APOB OGFOD3 PRPF8 KRT79 SPTBN4 SART1 SNRNP48 EIF5B PRKDC EMC2 CDC27 XRCC6 DOP1A | 3.14e-12 | 1442 | 235 | 37 | 35575683 | |
| Pubmed | TRIO USP11 SPTB NCAPH2 IQGAP1 CRNKL1 NDRG1 PKD1 MIGA1 PLEC CHPF SMURF2 RBM11 SUPT20H KALRN UBR4 NUCB1 CTDSP1 PRPF8 SHROOM2 FAF1 LDB2 KIF3A SPTBN4 VPS9D1 SNRNP48 CEP70 LRP4 PRKDC XRCC6 | 3.90e-09 | 1285 | 235 | 30 | 35914814 | |
| Pubmed | SART3 TPR USP11 MCM6 SMYD5 IQGAP1 CRNKL1 JMJD6 MKI67 IRF2BPL PLEC SUPT20H RBM4 UBR4 NUMA1 SAE1 HAT1 GINS4 PRPF8 SART1 ASNS CTNNBL1 EIF5B PRKDC XRCC6 AQR | 7.08e-09 | 1014 | 235 | 26 | 32416067 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | TPR EPPK1 NCAPH2 IQGAP1 PLEC NUP107 UBR4 NUMA1 SAE1 PRPF8 SART1 ASNS CTNNBL1 PRKDC LAS1L | 9.80e-09 | 332 | 235 | 15 | 32786267 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UTP6 SART3 TPR USP11 MCM6 NDUFS1 IQGAP1 CRNKL1 PTPN12 MKI67 AP1M1 PLEC NUP107 UBR4 NUMA1 SAE1 DHX57 PRPF8 SART1 ARHGEF40 SEC24C ASNS CTNNBL1 EIF5B PRKDC LAS1L CDC27 DHX34 XRCC6 AQR | 1.25e-08 | 1353 | 235 | 30 | 29467282 |
| Pubmed | Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. | 1.42e-08 | 25 | 235 | 6 | 8493579 | |
| Pubmed | SART3 MCM6 NDUFS1 IQGAP1 CRNKL1 AP1M1 PLEC NUP107 RBM4 UBR4 HAT1 COPG2 PRPF8 FAF1 SEC24C ASNS EIF5B PRKDC LAS1L XRCC6 | 1.67e-08 | 638 | 235 | 20 | 33239621 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHB1 PCDHGB7 PCDHGB2 PCDHGA11 PCDHGA2 PCDHB16 CELSR1 PCDH8 | 3.18e-08 | 72 | 235 | 8 | 10380929 |
| Pubmed | PCDHB1 PCDHGB7 PCDHGB2 PCDHGA11 PCDHGA2 PCDHB16 CELSR1 PCDH8 | 5.43e-08 | 77 | 235 | 8 | 10835267 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | SART3 TPR SYNE2 NUP107 UBR4 NUMA1 HAT1 PRPF8 WDR37 ATL1 KIF3A SEC24C ASNS CTNNBL1 EIF5B XRCC6 AQR | 6.15e-08 | 498 | 235 | 17 | 36634849 |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHB1 PCDHGB7 PCDHGB2 PCDHGA11 PCDHGA2 PCDHB16 CELSR1 PCDH8 | 7.36e-08 | 80 | 235 | 8 | 10716726 |
| Pubmed | TPR MCM6 ZC3H6 NDUFS1 IQGAP1 CRNKL1 NDRG1 MKI67 HRAS ASCC2 USP15 KRAS NUP107 NUMA1 SAE1 COPG2 PATL1 PRPF8 KIF3A FAM83B SART1 SEC24C ASNS EIF5B PRKDC XRCC6 AQR | 1.15e-07 | 1247 | 235 | 27 | 27684187 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | UTP6 TPR EPPK1 EMC1 MCM6 IQGAP1 CRNKL1 SYNE2 MKI67 PLEC NUP107 RBM4B RBM4 NUMA1 PRPF8 FAM83B SART1 SEC24C EIF5B PRKDC LAS1L EMC2 XRCC6 AQR | 1.47e-07 | 1024 | 235 | 24 | 24711643 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | TRIO IQGAP1 PLEC NUP107 NUMA1 DHX57 PRPF8 ARHGEF40 EIF5B PRKDC XRCC6 | 1.48e-07 | 202 | 235 | 11 | 33005030 |
| Pubmed | TPR TRIO MAP3K5 IQGAP1 KIF3B SYNE2 HRAS KRAS KALRN UBR4 NUMA1 GRM3 ATF6B LDB2 KIF3A SPTBN4 SART1 GDA SEC24C DCHS1 FRMPD3 PCDH8 XRCC6 | 1.95e-07 | 963 | 235 | 23 | 28671696 | |
| Pubmed | Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules. | 3.05e-07 | 3 | 235 | 3 | 28116986 | |
| Pubmed | Kinesin-2 KIF3AC and KIF3AB Can Drive Long-Range Transport along Microtubules. | 3.05e-07 | 3 | 235 | 3 | 26445448 | |
| Pubmed | Mutations of RAS gene family in specimens of bladder cancer. | 3.05e-07 | 3 | 235 | 3 | 19101897 | |
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 33620658 | ||
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 22589270 | ||
| Pubmed | A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation. | 3.05e-07 | 3 | 235 | 3 | 23496764 | |
| Pubmed | Distribution of p21ras during primary palate formation of non-cleft and cleft strains of mice. | 3.05e-07 | 3 | 235 | 3 | 7776260 | |
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 25788415 | ||
| Pubmed | Comparison of liver oncogenic potential among human RAS isoforms. | 3.05e-07 | 3 | 235 | 3 | 26799184 | |
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 31906952 | ||
| Pubmed | Partial functional overlap of the three ras genes in mouse embryonic development. | 3.05e-07 | 3 | 235 | 3 | 18059342 | |
| Pubmed | Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series. | 3.05e-07 | 3 | 235 | 3 | 23240926 | |
| Pubmed | Absolute Quantification of Endogenous Ras Isoform Abundance. | 3.05e-07 | 3 | 235 | 3 | 26560143 | |
| Pubmed | Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. | 3.05e-07 | 3 | 235 | 3 | 17712732 | |
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 24222113 | ||
| Pubmed | Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis. | 3.05e-07 | 3 | 235 | 3 | 22945650 | |
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 19303097 | ||
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 27911734 | ||
| Pubmed | Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients. | 3.05e-07 | 3 | 235 | 3 | 20150643 | |
| Pubmed | K-ras is an essential gene in the mouse with partial functional overlap with N-ras. | 3.05e-07 | 3 | 235 | 3 | 9334313 | |
| Pubmed | RAS gene mutations and histomorphometric measurements in oral squamous cell carcinoma. | 3.05e-07 | 3 | 235 | 3 | 37013448 | |
| Pubmed | Heterodimerization of Kinesin-2 KIF3AB Modulates Entry into the Processive Run. | 3.05e-07 | 3 | 235 | 3 | 27637334 | |
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 25977330 | ||
| Pubmed | Expression of KIF3C kinesin during neural development and in vitro neuronal differentiation. | 3.05e-07 | 3 | 235 | 3 | 11331403 | |
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 28630043 | ||
| Pubmed | Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer. | 3.05e-07 | 3 | 235 | 3 | 28259994 | |
| Pubmed | The variable phenotype and low-risk nature of RAS-positive thyroid nodules. | 3.05e-07 | 3 | 235 | 3 | 26253102 | |
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 16573741 | ||
| Pubmed | Analysis of k-ras nuclear expression in fibroblasts and mesangial cells. | 3.05e-07 | 3 | 235 | 3 | 20090846 | |
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 21737741 | ||
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 17943694 | ||
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 28202657 | ||
| Pubmed | Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma. | 3.05e-07 | 3 | 235 | 3 | 16761621 | |
| Pubmed | Kinesin-2 and photoreceptor cell death: requirement of motor subunits. | 3.05e-07 | 3 | 235 | 3 | 16337628 | |
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 20971740 | ||
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 27488117 | ||
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 27119512 | ||
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 4.02e-07 | 68 | 235 | 7 | 11230163 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 7.20e-07 | 74 | 235 | 7 | 10817752 | |
| Pubmed | EPPK1 NDE1 NUP210L CNTROB FIG4 SYNE2 MKI67 KRAS FAT4 NUP107 CNTRL APOB PRPF8 SART1 SEC24C DCHS1 CTNNBL1 SV2C XRCC6 | 1.08e-06 | 754 | 235 | 19 | 35906200 | |
| Pubmed | 1.21e-06 | 4 | 235 | 3 | 10085069 | ||
| Pubmed | 1.21e-06 | 4 | 235 | 3 | 38849523 | ||
| Pubmed | 1.21e-06 | 4 | 235 | 3 | 9674433 | ||
| Pubmed | Quantification of spatiotemporal patterns of Ras isoform expression during development. | 1.21e-06 | 4 | 235 | 3 | 28117393 | |
| Pubmed | The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions. | 1.21e-06 | 4 | 235 | 3 | 27936046 | |
| Pubmed | Reducing Pericyte-Derived Scarring Promotes Recovery after Spinal Cord Injury. | 1.21e-06 | 4 | 235 | 3 | 29502968 | |
| Pubmed | Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. | 1.21e-06 | 4 | 235 | 3 | 7972015 | |
| Pubmed | 1.21e-06 | 4 | 235 | 3 | 10490827 | ||
| Pubmed | Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding. | 1.21e-06 | 4 | 235 | 3 | 25999467 | |
| Pubmed | 1.21e-06 | 4 | 235 | 3 | 34948093 | ||
| Pubmed | Ras membrane orientation and nanodomain localization generate isoform diversity. | 1.21e-06 | 4 | 235 | 3 | 20080631 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | UTP6 SART3 TPR EMC1 TRIO MCM6 NDUFS1 IQGAP1 CRNKL1 MKI67 AP1M1 KIF3C NUP107 RBM4 UBR4 NUMA1 HAT1 APOB PRPF8 SART1 ASNS CTNNBL1 EIF5B PRKDC EMC2 XRCC6 AQR | 1.52e-06 | 1425 | 235 | 27 | 30948266 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | UTP6 SART3 EPPK1 EMC1 MCM6 IQGAP1 AP1M1 DNAH8 UBR4 NUMA1 SAE1 HAT1 COPG2 PRPF8 SEC24C ASNS CTNNBL1 PRKDC | 1.70e-06 | 704 | 235 | 18 | 29955894 |
| Pubmed | 1.93e-06 | 14 | 235 | 4 | 25359213 | ||
| Pubmed | Genome-wide association study of lung function decline in adults with and without asthma. | 2.34e-06 | 32 | 235 | 5 | 22424883 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | PIGN ABCC3 EMC1 NAGLU NCAPH2 ITGAV PTPN12 SCAPER CHPF USP15 COL1A1 FAT4 RBM4 NUCB1 LAMA4 OGFOD3 ATF6B CELSR1 SEC24C ANO6 RRAGA LRP4 EMC2 IL1RAP | 2.45e-06 | 1201 | 235 | 24 | 35696571 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TPR EPPK1 IQGAP1 PLEC NUP107 RBM4 COPG2 PRPF8 FAF1 SART1 SEC24C PRKDC LAS1L CDC27 XRCC6 AQR | 2.60e-06 | 582 | 235 | 16 | 20467437 |
| Pubmed | 2.62e-06 | 15 | 235 | 4 | 23831572 | ||
| Pubmed | 3.02e-06 | 5 | 235 | 3 | 22982107 | ||
| Pubmed | 3.02e-06 | 5 | 235 | 3 | 9069260 | ||
| Pubmed | Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions. | 3.02e-06 | 5 | 235 | 3 | 34535655 | |
| Pubmed | Impeded Nedd4-1-mediated Ras degradation underlies Ras-driven tumorigenesis. | 3.02e-06 | 5 | 235 | 3 | 24746824 | |
| Pubmed | Activated Ras induces lens epithelial cell hyperplasia but not premature differentiation. | 3.02e-06 | 5 | 235 | 3 | 15558479 | |
| Pubmed | PTPN12 KIF3B PKD1 ASCC2 PLEC CHPF SMURF2 NID2 RBM4 UBR4 SMURF1 LAMA4 FAF1 LDB2 IL1RAP XRCC6 | 3.16e-06 | 591 | 235 | 16 | 15231748 | |
| Pubmed | SART3 EMC1 USP11 UNC5B NDUFS1 DNAJB13 SYNE2 VPS13A ASCC2 DPH1 DNAJC4 DDX31 NUP107 UBR4 NUCB1 PRPF8 ATF6B FAM83B SEC24C ANO6 ASNS EIF5B LAS1L EMC2 XRCC6 AQR HERC5 | 3.35e-06 | 1487 | 235 | 27 | 33957083 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | UTP6 MCM6 NDUFS1 CRNKL1 JMJD6 MKI67 AP1M1 PLEC DDX31 RBM4 UBR4 NUMA1 SAE1 HAT1 COPG2 PATL1 PRPF8 SEC24C CTNNBL1 EIF5B PRKDC LAS1L CDC27 XRCC6 AQR | 3.73e-06 | 1318 | 235 | 25 | 30463901 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SART3 TPR EPPK1 EMC1 MCM6 IQGAP1 CRNKL1 JMJD6 SYNE2 AP1M1 PLEC RBM4 UBR4 NUMA1 PATL1 PRPF8 KRT79 SART1 GDA SEC24C CTNNBL1 EIF5B PRKDC EMC2 XRCC6 AQR | 4.17e-06 | 1415 | 235 | 26 | 28515276 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | EPPK1 MCM6 NDUFS1 IQGAP1 CRNKL1 PLEC COL1A1 NUMA1 PRPF8 SART1 ASNS EIF5B PRKDC XRCC6 | 5.32e-06 | 477 | 235 | 14 | 31300519 |
| Pubmed | SART3 NDE1 USP11 ITGAV ASCC2 PLEC USP15 APPBP2 UBR4 FCHO2 FAF1 PLD6 CDC27 XRCC6 | 5.85e-06 | 481 | 235 | 14 | 28190767 | |
| Pubmed | 5.90e-06 | 101 | 235 | 7 | 18519826 | ||
| Pubmed | Glutamate transporter Slc1a3 mediates inter-niche stem cell activation during skin growth. | 6.00e-06 | 6 | 235 | 3 | 29615452 | |
| Pubmed | 6.00e-06 | 6 | 235 | 3 | 9753431 | ||
| Pubmed | 6.00e-06 | 6 | 235 | 3 | 21072204 | ||
| Pubmed | 6.00e-06 | 6 | 235 | 3 | 10882715 | ||
| Pubmed | 6.00e-06 | 6 | 235 | 3 | 28088760 | ||
| Pubmed | LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases. | 6.00e-06 | 6 | 235 | 3 | 31337872 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | PDE8A MYH13 SERPINF1 LRRK2 NAGLU ADGRV1 ITGAV RYR1 IQGAP1 KIF3B NDRG1 PKD1 AP1M1 ALDH1A1 KALRN ANXA13 SMURF1 SHROOM2 KIF3A GSS ANO6 | 6.46e-06 | 1016 | 235 | 21 | 19056867 |
| Pubmed | 6.59e-06 | 144 | 235 | 8 | 35681168 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | SART3 USP11 MCM6 IQGAP1 PTPN12 NDRG1 JMJD6 AP1M1 IRF2BPL PLEC USP15 FNTA UBR4 NUCB1 SAE1 HAT1 GINS4 SCLY FAF1 GSS GDA SEC24C ASNS EIF5B PRKDC XRCC6 | 6.84e-06 | 1455 | 235 | 26 | 22863883 |
| Pubmed | USP11 MCM6 NDUFS1 IQGAP1 ASCC2 AP1M1 NUP107 NUMA1 HAT1 COPG2 PRPF8 ASNS LAS1L CDC27 AQR | 7.33e-06 | 560 | 235 | 15 | 35241646 | |
| Pubmed | SART3 TMA16 MYH13 ITGAV ITIH3 IQGAP1 CRNKL1 MKI67 ASCC2 PLEC DDX31 NRAS RBM4B NUMA1 SAE1 DHX57 APOB PATL1 SIRT7 PRPF8 ARHGEF40 SEC24C CTNNBL1 LAS1L XRCC6 | 7.37e-06 | 1371 | 235 | 25 | 36244648 | |
| Pubmed | EMC1 PDE8A ITGAV FIG4 SYNE2 VPS13A MIGA1 DHX57 ATF6B ATL1 FAM83B ANO6 RRAGA EMC2 | 9.89e-06 | 504 | 235 | 14 | 34432599 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TRIO SPTB ADGRV1 PTPRB NDRG1 USP15 SMURF2 RPS6KL1 RBM4 SMURF1 SRCIN1 ST3GAL3 PATL1 WDR37 SHROOM2 ATP10A FAF1 PCDHB16 SPTBN4 EVA1C PARP10 NADSYN1 RASEF NRG3 CSMD1 DOP1A | 1.02e-05 | 1489 | 235 | 26 | 28611215 |
| Pubmed | 1.04e-05 | 7 | 235 | 3 | 20058854 | ||
| Interaction | SIRT7 interactions | UTP6 SART3 TPR EPPK1 USP11 MCM6 NDUFS1 IQGAP1 CRNKL1 SYNE2 MKI67 PLEC DDX31 NUP107 UBR4 NUMA1 DHX57 COPG2 SIRT7 PRPF8 SART1 SEC24C ASNS CTNNBL1 EIF5B PRKDC LAS1L XRCC6 AQR HERC5 | 2.22e-09 | 744 | 231 | 30 | int:SIRT7 |
| Interaction | SPTA1 interactions | 1.34e-06 | 94 | 231 | 9 | int:SPTA1 | |
| Interaction | SUMO2 interactions | TPR EPPK1 USP11 LRRK2 NCAPH2 IQGAP1 SIMC1 MKI67 PLEC KRAS NUP107 KALRN UBR4 NUMA1 SAE1 PRPF8 SART1 ASNS CTNNBL1 PRKDC LAS1L XRCC6 | 1.35e-06 | 591 | 231 | 22 | int:SUMO2 |
| Interaction | DCPS interactions | SART3 TPR MKI67 AP1M1 PLEC KRAS NUP107 AP1M2 SAE1 GINS4 PRPF8 GSS SART1 ASNS PRKDC LAS1L CDC27 | 3.26e-06 | 394 | 231 | 17 | int:DCPS |
| Interaction | CDC5L interactions | UTP6 TPR EPPK1 KCTD13 TRIO IQGAP1 CRNKL1 KIF3C PLEC PURG KRAS NUP107 KALRN RBM4B RBM4 COPG2 PRPF8 FAF1 SART1 SEC24C CTNNBL1 MOB3C PRKDC LAS1L CDC27 AQR | 5.99e-06 | 855 | 231 | 26 | int:CDC5L |
| Interaction | GTSF1 interactions | 7.75e-06 | 12 | 231 | 4 | int:GTSF1 | |
| Interaction | ITGB6 interactions | 1.54e-05 | 14 | 231 | 4 | int:ITGB6 | |
| Interaction | DYNC1H1 interactions | TPR EPPK1 EMC1 KCTD13 USP11 LRRK2 IQGAP1 KIF3B USP15 RPS6KL1 KRAS CNTRL NUMA1 SIRT7 PRPF8 MOB3C RASEF PRKDC | 1.57e-05 | 491 | 231 | 18 | int:DYNC1H1 |
| Interaction | ITGB1 interactions | TPR EMC1 ITGAV IQGAP1 HRAS PLEC DNAH8 COL1A1 KRAS NRAS UBR4 ITGA8 PRPF8 PLD6 PRKDC EMC2 | 1.64e-05 | 400 | 231 | 16 | int:ITGB1 |
| Interaction | PPIAL4G interactions | 2.14e-05 | 30 | 231 | 5 | int:PPIAL4G | |
| Interaction | TPR interactions | SART3 TPR EMC1 LRRK2 HRAS KRAS NUP107 RBM4 SIRT7 SART1 MOB3C PRKDC XRCC6 | 2.32e-05 | 281 | 231 | 13 | int:TPR |
| Interaction | LRRC31 interactions | TRIO IQGAP1 PLEC NUP107 NUMA1 DHX57 PRPF8 ARHGEF40 EIF5B PRKDC XRCC6 | 2.59e-05 | 205 | 231 | 11 | int:LRRC31 |
| Interaction | ITGB3 interactions | 2.76e-05 | 170 | 231 | 10 | int:ITGB3 | |
| Interaction | PCDHGB1 interactions | 2.89e-05 | 77 | 231 | 7 | int:PCDHGB1 | |
| Interaction | HEPH interactions | 2.90e-05 | 6 | 231 | 3 | int:HEPH | |
| Interaction | ATP1A1 interactions | SART3 EMC1 KCTD13 USP11 NDUFS1 IQGAP1 NDRG1 PKD1 HRAS ALDH1A1 KRAS NRAS NUP107 DHX57 SIRT7 PRPF8 PRKDC EMC2 XRCC6 | 3.79e-05 | 575 | 231 | 19 | int:ATP1A1 |
| Interaction | SART3 interactions | SART3 TPR KCTD13 USP15 KRAS DDX31 UBR4 DHX57 SIRT7 PRPF8 RSPH3 MOB3C XRCC6 | 3.98e-05 | 296 | 231 | 13 | int:SART3 |
| Interaction | PLCD1 interactions | 4.28e-05 | 56 | 231 | 6 | int:PLCD1 | |
| Interaction | SLC2A3 interactions | 4.65e-05 | 35 | 231 | 5 | int:SLC2A3 | |
| Interaction | DCANP1 interactions | 5.69e-05 | 19 | 231 | 4 | int:DCANP1 | |
| Interaction | TADA1 interactions | 6.97e-05 | 61 | 231 | 6 | int:TADA1 | |
| Interaction | CKB interactions | KCTD13 LRRK2 CNTROB IQGAP1 USP15 CNTRL SCLY SIRT7 PRPF8 MOB3C CDC27 XRCC6 | 7.04e-05 | 270 | 231 | 12 | int:CKB |
| Interaction | SUSD5 interactions | 7.05e-05 | 20 | 231 | 4 | int:SUSD5 | |
| Interaction | ISY1-RAB43 interactions | 7.94e-05 | 39 | 231 | 5 | int:ISY1-RAB43 | |
| Interaction | ARHGAP5 interactions | 8.37e-05 | 63 | 231 | 6 | int:ARHGAP5 | |
| Interaction | TAOK3 interactions | 9.15e-05 | 64 | 231 | 6 | int:TAOK3 | |
| Interaction | ATP2B4 interactions | 9.19e-05 | 196 | 231 | 10 | int:ATP2B4 | |
| Interaction | CTNNB1 interactions | KCTD13 USP11 LRRK2 IQGAP1 KIF3B NDRG1 SYNE2 PKD1 MKI67 HRAS IRF2BPL ALDH1A1 USP15 KRAS NRAS NUMA1 SMURF1 SRCIN1 FAF1 KIF3A SEC24C MOB3C PRKDC CDC27 XRCC6 HERC5 | 9.94e-05 | 1009 | 231 | 26 | int:CTNNB1 |
| Interaction | DONSON interactions | 1.01e-04 | 41 | 231 | 5 | int:DONSON | |
| Interaction | RHOB interactions | PHACTR2 EPPK1 TRIO UNC5B ITGAV NDUFS1 IQGAP1 NDRG1 VPS13A FAT4 SDK2 DDX31 FNTA SMURF1 CTDSP1 FCHO2 FAM83B ANO6 ASNS LRP4 EMC2 IL1RAP CDC27 | 1.05e-04 | 840 | 231 | 23 | int:RHOB |
| Interaction | NUP210P1 interactions | 1.14e-04 | 42 | 231 | 5 | int:NUP210P1 | |
| Interaction | OBSL1 interactions | UTP6 TPR TMA16 EPPK1 MCM6 IQGAP1 CRNKL1 SYNE2 MKI67 PLEC KRAS NUP107 RBM4B RBM4 NUMA1 DHX57 PRPF8 SART1 SEC24C EIF5B PRKDC LAS1L XRCC6 AQR | 1.15e-04 | 902 | 231 | 24 | int:OBSL1 |
| Interaction | LRP6 interactions | 1.16e-04 | 128 | 231 | 8 | int:LRP6 | |
| Interaction | MSN interactions | USP11 LRRK2 HRAS PLEC KRAS NRAS CNTRL SMURF1 SIRT7 SHROOM2 GSS SEC24C ASNS | 1.20e-04 | 330 | 231 | 13 | int:MSN |
| Interaction | SIRT6 interactions | SART3 USP11 MCM6 MKI67 ASCC2 USP15 FAT4 DDX31 NUP107 NUMA1 PRPF8 FAF1 CELSR1 PRKDC LAS1L EMC2 CDC27 XRCC6 AQR | 1.21e-04 | 628 | 231 | 19 | int:SIRT6 |
| Interaction | NAV2 interactions | 1.28e-04 | 43 | 231 | 5 | int:NAV2 | |
| Interaction | NOP53 interactions | MKI67 USP15 RPS6KL1 PURG KRAS DDX31 RBM4B SIRT7 CEP70 EIF5B MOB3C XRCC6 | 1.30e-04 | 288 | 231 | 12 | int:NOP53 |
| Interaction | TNIK interactions | TPR TRIO NDE1 SYNE2 HRAS KRAS NRAS FNTA KALRN SMURF1 SART1 SEC24C DCHS1 PCDH8 | 1.37e-04 | 381 | 231 | 14 | int:TNIK |
| Interaction | VDAC2 interactions | ABCC3 EMC1 KCTD13 USP11 LRRK2 ITGAV NDUFS1 IQGAP1 MKI67 DNAH8 SMURF1 FAF1 RRAGA EMC2 XRCC6 | 1.48e-04 | 432 | 231 | 15 | int:VDAC2 |
| Interaction | TRPV2 interactions | 1.68e-04 | 10 | 231 | 3 | int:TRPV2 | |
| Interaction | ZBTB12 interactions | 1.68e-04 | 10 | 231 | 3 | int:ZBTB12 | |
| Interaction | ANKS4B interactions | 1.68e-04 | 10 | 231 | 3 | int:ANKS4B | |
| Interaction | DAB2IP interactions | 1.85e-04 | 103 | 231 | 7 | int:DAB2IP | |
| Interaction | TULP3 interactions | USP11 SPTB RYR1 MAP3K5 JMJD6 HRAS ASCC2 KRAS DPH1 NRAS RBM4 HAT1 KIF3A | 1.91e-04 | 346 | 231 | 13 | int:TULP3 |
| Interaction | KIF3C interactions | 2.06e-04 | 26 | 231 | 4 | int:KIF3C | |
| Interaction | VGLL4 interactions | 2.06e-04 | 26 | 231 | 4 | int:VGLL4 | |
| Interaction | XPO7 interactions | 2.11e-04 | 177 | 231 | 9 | int:XPO7 | |
| Interaction | CD160 interactions | 2.17e-04 | 48 | 231 | 5 | int:CD160 | |
| Interaction | ANXA1 interactions | EMC1 KCTD13 HRAS KRAS NRAS SIRT7 PRPF8 FAF1 ZSCAN20 MOB3C EMC2 XRCC6 | 2.27e-04 | 306 | 231 | 12 | int:ANXA1 |
| Interaction | SNCA interactions | SART3 TPR LRRK2 SYNE2 USP15 SMURF2 NUP107 UBR4 NUMA1 HAT1 PRPF8 WDR37 ATL1 KIF3A ASNS CTNNBL1 EIF5B XRCC6 AQR HERC5 | 2.32e-04 | 716 | 231 | 20 | int:SNCA |
| Interaction | ZNF830 interactions | 2.38e-04 | 76 | 231 | 6 | int:ZNF830 | |
| Interaction | PHLDB1 interactions | 2.40e-04 | 49 | 231 | 5 | int:PHLDB1 | |
| Interaction | PLIN2 interactions | 2.40e-04 | 27 | 231 | 4 | int:PLIN2 | |
| Interaction | FRAT2 interactions | 2.40e-04 | 27 | 231 | 4 | int:FRAT2 | |
| Interaction | SPECC1 interactions | 2.49e-04 | 143 | 231 | 8 | int:SPECC1 | |
| Interaction | DCTN2 interactions | TPR KCTD13 MCM6 CNTROB KCNA5 USP15 KRAS SMURF1 SAE1 FAF1 KIF3A CTNNBL1 MOB3C | 2.51e-04 | 356 | 231 | 13 | int:DCTN2 |
| Interaction | ZRSR2 interactions | 2.56e-04 | 77 | 231 | 6 | int:ZRSR2 | |
| Interaction | UBE2R2 interactions | 2.56e-04 | 77 | 231 | 6 | int:UBE2R2 | |
| Interaction | NHERF2 interactions | 2.71e-04 | 183 | 231 | 9 | int:NHERF2 | |
| Interaction | CIT interactions | UTP6 TPR EPPK1 KCTD13 SPTB LRRK2 ADGRV1 MAP3K5 IQGAP1 CRNKL1 SYNE2 MKI67 PLEC DDX31 NUP107 KALRN RBM4B UBR4 NUMA1 DHX57 APOB PRPF8 SPTBN4 SART1 DNAH12 SEC24C CTNNBL1 EIF5B PRKDC LAS1L XRCC6 AQR | 2.72e-04 | 1450 | 231 | 32 | int:CIT |
| Interaction | LSM5 interactions | 2.74e-04 | 78 | 231 | 6 | int:LSM5 | |
| Interaction | SUPT5H interactions | EMC1 CRNKL1 SYNE2 UBR4 SIRT7 PRPF8 SART1 SNRNP48 SEC24C EIF5B MOB3C EMC2 XRCC6 AQR | 2.76e-04 | 408 | 231 | 14 | int:SUPT5H |
| Interaction | VPS51 interactions | 2.93e-04 | 185 | 231 | 9 | int:VPS51 | |
| Interaction | TAC1 interactions | 3.03e-04 | 12 | 231 | 3 | int:TAC1 | |
| Interaction | SNRPN interactions | 3.05e-04 | 186 | 231 | 9 | int:SNRPN | |
| Interaction | PTCH1 interactions | ITGAV FIG4 CHPF USP15 SMURF2 APPBP2 SMURF1 ITGA8 ACAD10 ATF6B CELSR1 | 3.28e-04 | 273 | 231 | 11 | int:PTCH1 |
| Interaction | RHOD interactions | EMC1 SPTB MCM6 ITGAV NDUFS1 IQGAP1 SYNE2 VPS13A HRAS SMURF2 KRAS DDX31 CTDSP1 FCHO2 FAM83B ANO6 EMC2 | 3.41e-04 | 572 | 231 | 17 | int:RHOD |
| Interaction | GAK interactions | 3.43e-04 | 189 | 231 | 9 | int:GAK | |
| Interaction | NEFM interactions | 3.57e-04 | 190 | 231 | 9 | int:NEFM | |
| Interaction | SLC1A4 interactions | 3.65e-04 | 30 | 231 | 4 | int:SLC1A4 | |
| Interaction | PHF7 interactions | 3.65e-04 | 30 | 231 | 4 | int:PHF7 | |
| Interaction | LSM2 interactions | 3.71e-04 | 191 | 231 | 9 | int:LSM2 | |
| Interaction | SF3A1 interactions | EMC1 LRRK2 MCM6 CRNKL1 PTPN12 KRAS SMURF1 PATL1 SIRT7 PRPF8 SART1 CTNNBL1 EMC2 XRCC6 AQR | 3.72e-04 | 471 | 231 | 15 | int:SF3A1 |
| Interaction | SPTBN1 interactions | KCTD13 USP11 IQGAP1 SYNE2 HRAS KRAS NRAS KALRN SMURF1 DHX57 SIRT7 SPTBN4 RRAGA XRCC6 | 3.79e-04 | 421 | 231 | 14 | int:SPTBN1 |
| Cytoband | 5q31 | 2.31e-06 | 115 | 235 | 7 | 5q31 | |
| Cytoband | 8p11 | 1.55e-04 | 4 | 235 | 2 | 8p11 | |
| Cytoband | 14q22.1 | 4.85e-04 | 30 | 235 | 3 | 14q22.1 | |
| Cytoband | 12q24.12 | 5.39e-04 | 7 | 235 | 2 | 12q24.12 | |
| GeneFamily | Clustered protocadherins | 1.43e-05 | 64 | 149 | 6 | 20 | |
| GeneFamily | Dyneins, axonemal | 3.43e-04 | 17 | 149 | 3 | 536 | |
| GeneFamily | Cadherin related | 3.43e-04 | 17 | 149 | 3 | 24 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 4.00e-04 | 4 | 149 | 2 | 1244 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.38e-03 | 7 | 149 | 2 | 1113 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.83e-03 | 8 | 149 | 2 | 939 | |
| GeneFamily | RAS type GTPase family | 2.08e-03 | 31 | 149 | 3 | 389 | |
| GeneFamily | Fibronectin type III domain containing | 2.12e-03 | 160 | 149 | 6 | 555 | |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN | 2.48e-06 | 165 | 234 | 10 | M8121 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-08 | 184 | 235 | 10 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | PTPN12 ALDH1A2 PTPRB NDRG1 SYNE2 SHROOM2 ATP10A LDB2 EVA1C NRG3 | 8.45e-08 | 193 | 235 | 10 | 2531266bc57339d4e2b22a88817008e32b8c1598 |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | CHL1 SERPINF1 LRRK2 ALDH1A1 COL1A1 ITGA8 LAMA4 ACAD10 PLA2G4C MYO16 | 1.02e-07 | 197 | 235 | 10 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | CHL1 SERPINF1 ALDH1A2 OLFML1 ALDH1A1 COL1A1 SDK2 ITGA8 LAMA4 MYO16 | 1.18e-07 | 200 | 235 | 10 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | CHL1 SERPINF1 ALDH1A2 OLFML1 ALDH1A1 COL1A1 SDK2 ITGA8 LAMA4 MYO16 | 1.18e-07 | 200 | 235 | 10 | 50ca6550998e461ef26dd670351060bd940765a8 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | CHL1 SERPINF1 ALDH1A2 OLFML1 ALDH1A1 COL1A1 SDK2 ITGA8 LAMA4 MYO16 | 1.18e-07 | 200 | 235 | 10 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | CHL1 SERPINF1 ALDH1A2 OLFML1 ALDH1A1 COL1A1 SDK2 ITGA8 LAMA4 MYO16 | 1.18e-07 | 200 | 235 | 10 | 44a68bacdb3d5bf563bd35952176995850933a81 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | CHL1 SERPINF1 ALDH1A2 OLFML1 ALDH1A1 COL1A1 SDK2 ITGA8 LAMA4 MYO16 | 1.18e-07 | 200 | 235 | 10 | dc61016c61729f69649cfb21f6264e685ce83dea |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.42e-07 | 185 | 235 | 9 | 10da5c2a92bfb3248d3f6f94a0933996326cf590 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.42e-07 | 185 | 235 | 9 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.42e-07 | 185 | 235 | 9 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.72e-07 | 186 | 235 | 9 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.39e-07 | 191 | 235 | 9 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.39e-07 | 191 | 235 | 9 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.76e-07 | 192 | 235 | 9 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.76e-07 | 192 | 235 | 9 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 9.15e-07 | 193 | 235 | 9 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.18e-06 | 199 | 235 | 9 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.18e-06 | 199 | 235 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.18e-06 | 199 | 235 | 9 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.18e-06 | 199 | 235 | 9 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.18e-06 | 199 | 235 | 9 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 1.18e-06 | 199 | 235 | 9 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.23e-06 | 200 | 235 | 9 | ab4fda0cc95cb8f80ea9f28745013f3248def820 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.23e-06 | 200 | 235 | 9 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-06 | 157 | 235 | 8 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.12e-06 | 159 | 235 | 8 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.05e-06 | 167 | 235 | 8 | a90f905ef38437752e2b0b71bd0322a184de1861 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 3.33e-06 | 169 | 235 | 8 | bea8aba1f3cc3d0e8d448c1c45f5354d26ebf850 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 5.09e-06 | 179 | 235 | 8 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-06 | 181 | 235 | 8 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-06 | 181 | 235 | 8 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-06 | 184 | 235 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-06 | 184 | 235 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-06 | 184 | 235 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Synpr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.25e-06 | 134 | 235 | 7 | 3dd4b5eddc94c1d49ab23b287ee234db3a55331b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.59e-06 | 189 | 235 | 8 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 7.59e-06 | 189 | 235 | 8 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.59e-06 | 189 | 235 | 8 | bd91bdfe35294e60d980259b70fe9e60dca2743f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.59e-06 | 189 | 235 | 8 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.89e-06 | 190 | 235 | 8 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.89e-06 | 190 | 235 | 8 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.20e-06 | 191 | 235 | 8 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.20e-06 | 191 | 235 | 8 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.20e-06 | 191 | 235 | 8 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Synpr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.39e-06 | 137 | 235 | 7 | b03f19b233c1c809f2cd2b4a7642eeaf254a6289 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.52e-06 | 192 | 235 | 8 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.52e-06 | 192 | 235 | 8 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | facs-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.52e-06 | 192 | 235 | 8 | 8df15085b35b86f39debd933284cb703c5dd63c2 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.18e-06 | 194 | 235 | 8 | ce32e60bcea1b8baf496ce9050832bc8c77d8434 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.18e-06 | 194 | 235 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.18e-06 | 194 | 235 | 8 | a1dc157148885cc8d3685ac81a1f4e3562aeecc9 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 9.18e-06 | 194 | 235 | 8 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.18e-06 | 194 | 235 | 8 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.03e-05 | 197 | 235 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-05 | 197 | 235 | 8 | d6c9da7a3a6d2bcb13e2fc6605c8a59e7fb121c5 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-05 | 197 | 235 | 8 | 80b05c8ad9c1edc5dea3236079372475431343fe | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.07e-05 | 198 | 235 | 8 | a54ae5275a510b49d7629f0908817a0c5f05020e | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 198 | 235 | 8 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 1.07e-05 | 198 | 235 | 8 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.07e-05 | 198 | 235 | 8 | 34997e3896d0893fbe51bfb0d4660ccaca1c975e | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.07e-05 | 198 | 235 | 8 | 686eda427b075e788de38149eae82faf19bd5704 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 199 | 235 | 8 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 199 | 235 | 8 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 199 | 235 | 8 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 199 | 235 | 8 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 199 | 235 | 8 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.15e-05 | 200 | 235 | 8 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 1.15e-05 | 200 | 235 | 8 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.15e-05 | 200 | 235 | 8 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 156 | 235 | 7 | 2ba838bc864c2c1767bcab7bb4d790af96b91387 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.95e-05 | 156 | 235 | 7 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Cpne5-Inhibitory_Gad1Gad2_Htr3a.Cpne5_(Interneuron,__(candidate_CGE-derived_5))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.38e-05 | 65 | 235 | 5 | a4873ffa71ac0016c9abce82cb4e1060946627cd | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Cpne5-Inhibitory_Gad1Gad2_Htr3a.Cpne5_(Interneuron,__(candidate_CGE-derived_5))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.38e-05 | 65 | 235 | 5 | 9cc767bfb26231af3bdb9423978b68ee42797cf4 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Cpne5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.38e-05 | 65 | 235 | 5 | db5db7d5811a714535bdb367c5e2863a3edf89a0 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 2.39e-05 | 161 | 235 | 7 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.39e-05 | 161 | 235 | 7 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.69e-05 | 164 | 235 | 7 | 3d8ff70fe5582d1fb56b338be8b76fa1428b3657 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-05 | 166 | 235 | 7 | 9adceb746e67e955fd8b3e0984f4eed44b64a270 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-05 | 168 | 235 | 7 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-05 | 168 | 235 | 7 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-05 | 169 | 235 | 7 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-05 | 169 | 235 | 7 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.39e-05 | 170 | 235 | 7 | 09bcbc7eb3b1d35cf03f01ce2f2fe37373382dd4 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 3.65e-05 | 172 | 235 | 7 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.93e-05 | 174 | 235 | 7 | e0de0a14319be1a115e5be05d6f9b562e7b32c4a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.93e-05 | 174 | 235 | 7 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.07e-05 | 175 | 235 | 7 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.22e-05 | 176 | 235 | 7 | 08f94b78b27feeb113dbfadbfa7fe34d08b2809b | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.22e-05 | 176 | 235 | 7 | 450c25ec5eeb65425f904e0a25aaafdf5682ef9c | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-05 | 177 | 235 | 7 | 8ef41ee5d63737b810ad7371b0437625e7e1badf | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.70e-05 | 179 | 235 | 7 | bc95c3e7edc5fc6fc913b09f087d221df64c6f48 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 180 | 235 | 7 | 12537d8a569faa69f474284d2c201475722b8ca1 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-05 | 182 | 235 | 7 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-05 | 182 | 235 | 7 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-05 | 182 | 235 | 7 | 010a7364da46101cb5068891fd7bc712ea8f13bd | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Dpy19l1_(Neuron.Gad1Gad2.Cplx3-Dpy19l1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.42e-05 | 77 | 235 | 5 | 4a0a2f1a021790ff598a8655811eac1c367316b3 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Dpy19l1_(Neuron.Gad1Gad2.Cplx3-Dpy19l1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.42e-05 | 77 | 235 | 5 | 459fe29a53b88af77a4ced7b11fa1d0a17fec8e5 | |
| ToppCell | normal-na-Lymphocytic-lymphocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.59e-05 | 184 | 235 | 7 | 2c286712428662bc4589dc5ac4011bf7ed403cb5 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.79e-05 | 185 | 235 | 7 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| Drug | Bergenin monohydrate [477-90-7]; Up 200; 11.6uM; MCF7; HT_HG-U133A | PIGN TPR TRIO RYR1 IQGAP1 KAZN KRAS DNAJC4 ZNF652 GINS4 PLA2G4C DHX34 | 9.11e-07 | 197 | 232 | 12 | 3467_UP |
| Drug | L 744832 | 4.15e-06 | 4 | 232 | 3 | ctd:C096898 | |
| Drug | Nimodipine [66085-59-4]; Down 200; 9.6uM; HL60; HT_HG-U133A | KCTD13 NDE1 HRAS DNAJC4 DDX31 OGFOD3 KCTD2 LAS1L IL1RAP DHX34 DOP1A | 4.96e-06 | 193 | 232 | 11 | 3103_DN |
| Drug | Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; PC3; HT_HG-U133A | ABCC3 GAS8 NCAPH2 FAT4 LAMA4 GINS4 ATP8B2 KMO ARHGEF40 HSD17B6 DHX34 | 5.74e-06 | 196 | 232 | 11 | 4482_UP |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Up 200; 7.8uM; HL60; HT_HG-U133A | PDE8A KCTD13 MAGEF1 HRAS SLC25A23 TMEM53 OGFOD3 LRRK1 KCTD2 IL1RAP DHX34 | 6.33e-06 | 198 | 232 | 11 | 1288_UP |
| Drug | diisopropanolnitrosamine | 1.03e-05 | 5 | 232 | 3 | ctd:C012457 | |
| Drug | PB-4 | 2.66e-05 | 35 | 232 | 5 | CID005289110 | |
| Drug | Sb-H | 3.07e-05 | 36 | 232 | 5 | CID005289334 | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 3.19e-05 | 194 | 232 | 10 | 4361_DN | |
| Drug | AG-028671 [847803-03-6]; Down 200; 10uM; PC3; HT_HG-U133A | 3.48e-05 | 196 | 232 | 10 | 6582_DN | |
| Drug | Metergoline [17692-51-2]; Down 200; 10uM; HL60; HG-U133A | 3.48e-05 | 196 | 232 | 10 | 1606_DN | |
| Drug | Riboflavine [83-88-5]; Down 200; 10.6uM; PC3; HT_HG-U133A | TMA16 KCTD13 NDE1 MAGEF1 MAP3K5 VPS13A KAZN FAT4 TMEM53 EIF5B | 3.64e-05 | 197 | 232 | 10 | 4485_DN |
| Drug | Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | NDE1 JADE3 NAGLU NCAPH2 SMURF1 OGFOD3 ATP8B2 VPS9D1 KCTD2 DHX34 | 3.79e-05 | 198 | 232 | 10 | 1491_DN |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; HL60; HT_HG-U133A | 3.79e-05 | 198 | 232 | 10 | 3117_DN | |
| Drug | Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; PC3; HT_HG-U133A | UNC5B GAS8 NCAPH2 JMJD6 SCAPER KAZN COL1A1 NUMA1 SMURF1 ACAD10 | 3.96e-05 | 199 | 232 | 10 | 4484_DN |
| Drug | Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; HL60; HT_HG-U133A | EMC1 SMYD5 NCAPH2 TUFT1 SCAPER SLC25A23 NUCB1 NUMA1 KCTD2 DOP1A | 3.96e-05 | 199 | 232 | 10 | 2449_DN |
| Drug | Lidoflazine [3416-26-0]; Down 200; 8.2uM; PC3; HT_HG-U133A | ABCC3 KCTD13 DPH1 FAT4 TMEM53 SUPT20H NUMA1 LAMA4 DNAH7 DHX34 | 3.96e-05 | 199 | 232 | 10 | 5804_DN |
| Disease | Verrucous epidermal nevus | 4.26e-07 | 3 | 223 | 3 | C0362030 | |
| Disease | Nevus Sebaceus of Jadassohn | 4.26e-07 | 3 | 223 | 3 | C4552097 | |
| Disease | Linear nevus sebaceous syndrome | 4.26e-07 | 3 | 223 | 3 | cv:C4552097 | |
| Disease | Nevus sebaceous | 4.26e-07 | 3 | 223 | 3 | C3854181 | |
| Disease | Inflammatory linear verrucous epidermal nevus | 4.26e-07 | 3 | 223 | 3 | C0473574 | |
| Disease | SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME | 4.26e-07 | 3 | 223 | 3 | 163200 | |
| Disease | linear nevus sebaceous syndrome (is_implicated_in) | 4.26e-07 | 3 | 223 | 3 | DOID:0111530 (is_implicated_in) | |
| Disease | Linear Verrucous Epidermal Nevus | 4.26e-07 | 3 | 223 | 3 | C3179502 | |
| Disease | cervical cancer (implicated_via_orthology) | 4.26e-07 | 3 | 223 | 3 | DOID:4362 (implicated_via_orthology) | |
| Disease | Organoid Nevus Phakomatosis | 4.26e-07 | 3 | 223 | 3 | C0265329 | |
| Disease | Noonan syndrome 3 (implicated_via_orthology) | 4.26e-07 | 3 | 223 | 3 | DOID:0060581 (implicated_via_orthology) | |
| Disease | NEVUS, EPIDERMAL (disorder) | 4.21e-06 | 5 | 223 | 3 | C0334082 | |
| Disease | Follicular thyroid carcinoma | 4.21e-06 | 5 | 223 | 3 | C0206682 | |
| Disease | Hemimegalencephaly | 8.38e-06 | 6 | 223 | 3 | C0431391 | |
| Disease | melanoma | 2.10e-05 | 248 | 223 | 10 | C0025202 | |
| Disease | neuroblastoma | 2.97e-05 | 116 | 223 | 7 | EFO_0000621 | |
| Disease | RASopathy (implicated_via_orthology) | 3.46e-05 | 9 | 223 | 3 | DOID:0080690 (implicated_via_orthology) | |
| Disease | Schizophrenia | CHL1 NDE1 NDUFS1 CHRNA3 ITIH3 ALDH1A2 ALDH1A1 HTR1F OFCC1 ITGA8 GRM3 KMO PLA2G4C NRG3 CSMD1 IL2 PCDH8 MYO16 GABBR1 | 4.63e-05 | 883 | 223 | 19 | C0036341 |
| Disease | chronic obstructive pulmonary disease, chronic bronchitis | 4.91e-05 | 10 | 223 | 3 | EFO_0000341, EFO_0006505 | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 5.69e-05 | 2 | 223 | 2 | 614470 | |
| Disease | Van Maldergem Wetzburger Verloes syndrome | 5.69e-05 | 2 | 223 | 2 | C1832390 | |
| Disease | Van Maldergem syndrome | 5.69e-05 | 2 | 223 | 2 | cv:C1832390 | |
| Disease | MELANOCYTIC NEVUS SYNDROME, CONGENITAL | 5.69e-05 | 2 | 223 | 2 | 137550 | |
| Disease | Melanocytic nevus | 5.69e-05 | 2 | 223 | 2 | cv:C0027962 | |
| Disease | Large congenital melanocytic nevus | 5.69e-05 | 2 | 223 | 2 | cv:C1842036 | |
| Disease | Periventricular gray matter heterotopia | 5.69e-05 | 2 | 223 | 2 | C1849173 | |
| Disease | Autoimmune lymphoproliferative syndrome type 4 | 5.69e-05 | 2 | 223 | 2 | cv:C2674723 | |
| Disease | autoimmune lymphoproliferative syndrome type 4 (is_implicated_in) | 5.69e-05 | 2 | 223 | 2 | DOID:0110117 (is_implicated_in) | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 5.69e-05 | 2 | 223 | 2 | C2674723 | |
| Disease | large congenital melanocytic nevus (is_implicated_in) | 5.69e-05 | 2 | 223 | 2 | DOID:0111359 (is_implicated_in) | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 6.50e-05 | 29 | 223 | 4 | DOID:11984 (implicated_via_orthology) | |
| Disease | Noonan Syndrome 1 | 6.72e-05 | 11 | 223 | 3 | C4551602 | |
| Disease | Turner Syndrome, Male | 6.72e-05 | 11 | 223 | 3 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 6.72e-05 | 11 | 223 | 3 | C1527404 | |
| Disease | kidney cancer (implicated_via_orthology) | 6.72e-05 | 11 | 223 | 3 | DOID:263 (implicated_via_orthology) | |
| Disease | prostate cancer (implicated_via_orthology) | 1.09e-04 | 33 | 223 | 4 | DOID:10283 (implicated_via_orthology) | |
| Disease | Heterotopia, Periventricular, Autosomal Recessive | 1.70e-04 | 3 | 223 | 2 | C1842563 | |
| Disease | GIANT PIGMENTED HAIRY NEVUS | 1.70e-04 | 3 | 223 | 2 | C1842036 | |
| Disease | Thyroid Neoplasm | 1.72e-04 | 37 | 223 | 4 | C0040136 | |
| Disease | RASopathy | 1.81e-04 | 15 | 223 | 3 | cv:C5555857 | |
| Disease | amino acid measurement | PIGN UTP6 NCAPH2 PTPRB KIF3C FAT4 SMURF1 LRRK1 DNAH7 DNAH12 UNC13C PRKDC NRG3 CSMD1 MYO16 | 2.20e-04 | 678 | 223 | 15 | EFO_0005134 |
| Disease | Colorectal Carcinoma | CHL1 ABCC3 ABCA9 KRT73 VPS13A MKI67 DNAH8 KRAS NRAS KALRN HAT1 PHETA1 APOB DCHS1 LAS1L | 3.18e-04 | 702 | 223 | 15 | C0009402 |
| Disease | Hemangiosarcoma | 3.20e-04 | 18 | 223 | 3 | C0018923 | |
| Disease | Malignant neoplasm of penis | 3.38e-04 | 4 | 223 | 2 | C0153601 | |
| Disease | Penile Neoplasms | 3.38e-04 | 4 | 223 | 2 | C0030849 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 3.38e-04 | 4 | 223 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | BLADDER CANCER | 3.38e-04 | 4 | 223 | 2 | 109800 | |
| Disease | Epidermal nevus | 3.38e-04 | 4 | 223 | 2 | cv:C0334082 | |
| Disease | Malignant tumor of urinary bladder | 3.38e-04 | 4 | 223 | 2 | cv:C0005684 | |
| Disease | Malignant tumor of cervix | 3.38e-04 | 4 | 223 | 2 | C0007847 | |
| Disease | epidermal nevus (is_implicated_in) | 3.38e-04 | 4 | 223 | 2 | DOID:0111162 (is_implicated_in) | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 3.38e-04 | 4 | 223 | 2 | 188470 | |
| Disease | carbon monoxide exhalation measurement | 3.38e-04 | 4 | 223 | 2 | EFO_0006520 | |
| Disease | NEVUS, EPIDERMAL | 3.38e-04 | 4 | 223 | 2 | 162900 | |
| Disease | Nevus, Keratinocytic, Nonepidermolytic | 3.38e-04 | 4 | 223 | 2 | C4011754 | |
| Disease | Thyroid cancer, nonmedullary, 2 | 3.38e-04 | 4 | 223 | 2 | cv:C4225426 | |
| Disease | high grade glioma (implicated_via_orthology) | 3.40e-04 | 44 | 223 | 4 | DOID:3070 (implicated_via_orthology) | |
| Disease | Thyroid carcinoma | 3.40e-04 | 44 | 223 | 4 | C0549473 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 3.77e-04 | 19 | 223 | 3 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 3.77e-04 | 19 | 223 | 3 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 3.77e-04 | 19 | 223 | 3 | C1275081 | |
| Disease | Costello syndrome (disorder) | 3.77e-04 | 19 | 223 | 3 | C0587248 | |
| Disease | leukemia (implicated_via_orthology) | 3.77e-04 | 19 | 223 | 3 | DOID:1240 (implicated_via_orthology) | |
| Disease | Renal Cell Carcinoma | 4.39e-04 | 128 | 223 | 6 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 4.39e-04 | 128 | 223 | 6 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 4.39e-04 | 128 | 223 | 6 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 4.39e-04 | 128 | 223 | 6 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 4.39e-04 | 128 | 223 | 6 | C1306837 | |
| Disease | caudate nucleus measurement, functional brain measurement, response to reward | 4.39e-04 | 47 | 223 | 4 | EFO_0007849, EFO_0008387, EFO_0008396 | |
| Disease | opioid dependence | 4.69e-04 | 237 | 223 | 8 | EFO_0005611 | |
| Disease | Malignant neoplasm of thyroid | 5.60e-04 | 5 | 223 | 2 | C0007115 | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 5.60e-04 | 5 | 223 | 2 | C4225426 | |
| Disease | Cetuximab response | 5.60e-04 | 5 | 223 | 2 | cv:CN077967 | |
| Disease | Cervix carcinoma | 5.60e-04 | 5 | 223 | 2 | C0302592 | |
| Disease | Panitumumab response | 5.60e-04 | 5 | 223 | 2 | cv:CN077999 | |
| Disease | LEOPARD Syndrome | 5.90e-04 | 22 | 223 | 3 | C0175704 | |
| Disease | Liver neoplasms | 7.59e-04 | 142 | 223 | 6 | C0023903 | |
| Disease | Malignant neoplasm of liver | 7.59e-04 | 142 | 223 | 6 | C0345904 | |
| Disease | Noonan Syndrome | 7.67e-04 | 24 | 223 | 3 | C0028326 | |
| Disease | mean platelet volume | NDE1 NUP210L LRRK2 FAM187B SYNE2 PLEC PCDHGB7 KALRN PCDHGB2 PCDHGA11 PCDHGA2 NUMA1 SMURF1 FCHO2 NARF RRAGA SV2C IL2 | 7.99e-04 | 1020 | 223 | 18 | EFO_0004584 |
| Disease | diffusing capacity of the lung for carbon monoxide | 8.25e-04 | 96 | 223 | 5 | EFO_0009369 | |
| Disease | Pleocytosis | 8.36e-04 | 6 | 223 | 2 | C0151857 | |
| Disease | Autoimmune lymphoproliferative syndrome | 8.36e-04 | 6 | 223 | 2 | cv:CN301239 | |
| Disease | seminoma (is_implicated_in) | 8.36e-04 | 6 | 223 | 2 | DOID:4440 (is_implicated_in) | |
| Disease | Carcinoma in situ of uterine cervix | 8.36e-04 | 6 | 223 | 2 | C0851140 | |
| Disease | Leukocytosis | 8.36e-04 | 6 | 223 | 2 | C0023518 | |
| Disease | paracentral lobule volume measurement | 8.66e-04 | 25 | 223 | 3 | EFO_0010317 | |
| Disease | hair colour measurement | CHL1 GAS8 ADGRV1 SYNE2 KRAS NRAS KRT87P ATP10A GSS VPS9D1 CTNNBL1 UNC13C EMC2 | 8.74e-04 | 615 | 223 | 13 | EFO_0007822 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 9.41e-04 | 148 | 223 | 6 | C0279702 | |
| Disease | FEV/FEC ratio | UTP6 CDH23 ITGAV CHRNA3 KIF3B SYNE2 SCAPER ASCC2 MIGA1 TRPM8 SMURF2 NID2 OFCC1 ITGA8 FAF1 LDB2 FAM83B DNAH12 CSMD1 MYO16 | 1.10e-03 | 1228 | 223 | 20 | EFO_0004713 |
| Disease | recalcitrant atopic dermatitis | 1.16e-03 | 7 | 223 | 2 | EFO_1000651 | |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 1.16e-03 | 7 | 223 | 2 | C1846545 | |
| Disease | Thyroid cancer, follicular | 1.16e-03 | 7 | 223 | 2 | C2931367 | |
| Disease | ataxia telangiectasia (is_implicated_in) | 1.16e-03 | 7 | 223 | 2 | DOID:12704 (is_implicated_in) | |
| Disease | memory performance | GAS8 ITIH3 SYNE2 KAZN FBXO33 PRPF8 PCDHB16 CTNNBL1 UNC13C CSMD1 | 1.18e-03 | 409 | 223 | 10 | EFO_0004874 |
| Disease | Autosomal Dominant Parkinsonism | 1.21e-03 | 28 | 223 | 3 | C0752098 | |
| Disease | Autosomal Dominant Juvenile Parkinson Disease | 1.21e-03 | 28 | 223 | 3 | C0752097 | |
| Disease | Parkinsonism, Experimental | 1.21e-03 | 28 | 223 | 3 | C0752101 | |
| Disease | Autosomal Recessive Parkinsonism | 1.21e-03 | 28 | 223 | 3 | C0752100 | |
| Disease | Familial Juvenile Parkinsonism | 1.21e-03 | 28 | 223 | 3 | C0752104 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LEVIRGDTFIQDYDE | 886 | Q5DID0 | |
| EARIFEETLNILIYE | 256 | Q8WZ19 | |
| ELYLFDVLRADRTTA | 396 | P08243 | |
| DNDVAREIRYLDEVL | 46 | Q9Y2D5 | |
| NVLEEIAELRREVSY | 1111 | Q7Z7A1 | |
| QVFQVVERTYREDAL | 31 | Q8TER5 | |
| ESIRDNFVIVYELLD | 101 | Q9Y6Q5 | |
| NYSFTREEVRQIDRE | 376 | Q9P2B7 | |
| DRFQTEVNYDTLEVR | 801 | Q96PZ7 | |
| EIIDNDTEEEFYLRR | 471 | Q8WYA6 | |
| HRLFERLFEDYNEII | 36 | P32297 | |
| AIALDRYRAITDAVE | 116 | P30939 | |
| IFVEESIYEEFVRRS | 326 | O94788 | |
| VELFIVADDTVYRRN | 201 | Q9H2U9 | |
| ELDLNYSIDAVRVIF | 116 | Q8IUA7 | |
| LVEEYLERATFVAND | 51 | Q9H1I8 | |
| RDTYALEQSLEFVRA | 101 | Q14832 | |
| ADFVRERATIEEAYS | 36 | Q0JRZ9 | |
| EIDREQIADFYLSVV | 3571 | Q6V0I7 | |
| IEEFFYINLTSVEIR | 5086 | Q8WXG9 | |
| ESIRDNFVIIYELLD | 101 | Q9BXS5 | |
| NIEASIREEDSFYVI | 806 | Q6JQN1 | |
| VEESIYDEFVRRSVE | 311 | P00352 | |
| LEDVLIEVFRTLYSQ | 371 | Q5JWR5 | |
| IQYQADRTDDIDREL | 606 | Q5JWR5 | |
| LRDRQYSVTDALEDV | 546 | Q92624 | |
| NLFRLESTYEIRQDI | 471 | O60306 | |
| EAYQRLFDRSLESDV | 126 | P27216 | |
| TRAVLDREEAAEYQL | 411 | Q9NYQ6 | |
| ELDFEVRREYVLVVQ | 1061 | Q9NYQ6 | |
| QDFRVLYVFVDIRID | 146 | Q9BZG8 | |
| AFIYDQTEDIRDVLR | 91 | Q13323 | |
| DDVYVDITDRLRFAI | 16 | A4D256 | |
| ERIAEYQLRVVASDA | 956 | Q9H251 | |
| DVELDRETIAFYNLT | 1806 | Q9H251 | |
| LAQEQESERELRYEA | 681 | O60312 | |
| FRYDLLDLTRQAVQE | 556 | P54802 | |
| QDSREDRLASIYEEV | 641 | P98198 | |
| RTENSERERDVYEEL | 276 | P46940 | |
| GVEDAFYTLVREIRQ | 151 | P01112 | |
| RVEDAFYTLVREIRQ | 151 | P01116 | |
| GVEDAFYTLVREIRQ | 151 | P01111 | |
| EEFEELVRAYGNIER | 156 | Q9HCJ3 | |
| NLEARVREEILYELF | 16 | P57052 | |
| REATEQEIRSLFEQY | 11 | Q9BWF3 | |
| ALRSFDYEQLRDLQV | 516 | Q9Y5H1 | |
| RAYTEDRNSLERQIE | 326 | Q8IZ41 | |
| FQSLRAEYEAIVREV | 26 | Q4KMZ1 | |
| YRDRIQSALEEESVF | 226 | P57740 | |
| FDYEQFRDLELRVIA | 521 | Q9Y5H2 | |
| RAEQRRVYLEGEFVE | 176 | P01893 | |
| IRAYNRSRDFEIISD | 1161 | O15438 | |
| VFSQDVYRVSLREDV | 241 | Q9Y5F8 | |
| IFREDSYILTVRENN | 451 | Q9Y5F3 | |
| QRRIDFVLVYEDESR | 66 | Q4KMQ2 | |
| QIRILTDARRSEDYE | 661 | P56975 | |
| VEDYERRYLLSLEEE | 536 | Q86TB9 | |
| DREERDAYNLRVTAT | 431 | Q96JQ0 | |
| NEVTDYAIARRIVDL | 541 | Q14566 | |
| YNFRIISLDEERTVV | 91 | P23467 | |
| NIFSEEDFRLYREVR | 171 | Q6PK18 | |
| EDVSVVRRTEFYFAQ | 1901 | Q14667 | |
| ALQLSVEEFVERYER | 51 | Q6NYC1 | |
| LESREEQLRDFIRNY | 166 | Q674X7 | |
| VQYREALADEADRAR | 271 | Q9HAY2 | |
| SIIAEVRAQYEEIAR | 301 | Q86Y46 | |
| DSIFQDVIETRGREY | 1056 | O00533 | |
| RFEPQINAEESEIRY | 486 | Q14409 | |
| RSRDDDVQYLTDRQL | 861 | Q38SD2 | |
| ARYDNAFIAEILIDR | 101 | Q9Y6X6 | |
| YARNAEEEEFVLLTL | 411 | Q9NPH3 | |
| RQDARIIVGLFYETE | 356 | Q9UBS5 | |
| QYELIAQRSRAEAEA | 321 | Q5XKE5 | |
| LVEEIDQRYFSIIDS | 186 | Q9BVA6 | |
| DERLITRLENTQYDA | 316 | O43679 | |
| VRELRVEFAAENYLS | 136 | Q7Z6M2 | |
| RVSDFLAEEEINYIL | 51 | Q5T0W9 | |
| VRASYLEIYQEEIRD | 141 | O14782 | |
| YEGADRIEFVIETAR | 41 | Q9H1B7 | |
| LSEEDLQFAERYLRS | 31 | P45452 | |
| VFSQDVYRVTLREDV | 241 | Q9Y5G2 | |
| DRERIAEYNLTLVAE | 456 | O95206 | |
| SFDYETLRQLDVRIQ | 566 | O95206 | |
| DAIEITSEDRFIQYA | 226 | O60658 | |
| LFINAYNSRRDLEIE | 226 | Q92597 | |
| FEQLSRVDDVYSVLR | 241 | Q9GZU7 | |
| VEVFREDVINFAEAY | 1201 | Q96JB1 | |
| LRIFEQYTIEVTAEL | 771 | O60229 | |
| EVLRVFYDRLINDDD | 2126 | Q6ZR08 | |
| EIFIDSIRRLENLYV | 186 | Q8N456 | |
| VQILEDLLVFTYSER | 36 | Q5S007 | |
| YERARELLVSYEEEQ | 266 | Q9Y4W2 | |
| VEALTQEIDFLRRLY | 61 | A6NCN2 | |
| SRAEIEFAVSRVDLY | 551 | Q96M69 | |
| DVITIIDRSFRYENE | 86 | P46013 | |
| RRILRFNEYVEVTDS | 571 | O75167 | |
| AAAIEEEIYQSLFLR | 326 | Q8N594 | |
| LDAEQRDDILYFSIR | 86 | Q9HC73 | |
| IRERATVLQTVFEDY | 686 | Q9H8H2 | |
| RVSYLEIYNEEVRDL | 146 | Q9Y496 | |
| AYTEEELRRFEEELA | 341 | Q02818 | |
| REATEQEIRSLFEQY | 11 | Q9BQ04 | |
| QDFIVYLRDETEFRD | 581 | P53708 | |
| QREIDYIQYLREADE | 96 | Q6UWY5 | |
| SAILELFEYIRVENI | 601 | Q6ZMV5 | |
| YLRSAAIEEERESEF | 661 | Q9UII4 | |
| VSREDDDRIFYNRLT | 111 | Q8IZS5 | |
| VDRVFALYNDEERVL | 726 | Q14112 | |
| ALYNDEERVLRFAVT | 731 | Q14112 | |
| VYISAVLRDQRIDDV | 6 | P60673 | |
| ERALDREARAEYNIT | 406 | Q9NRJ7 | |
| TEVIREYIFDQLRNL | 246 | Q9UP65 | |
| YSSIEAAELAERIER | 401 | P58658 | |
| VSATYELQREDRALV | 1016 | P04114 | |
| EAEAVREVYERAIAN | 506 | Q9BZJ0 | |
| EYADETATIVEFLNR | 126 | P60568 | |
| SFQELVEDYRRVIER | 401 | O14929 | |
| LLYVRRETEEVFDAL | 516 | Q8TE85 | |
| VSLDVFADEIRFYQL | 191 | P22460 | |
| NFQIDVYEAREDTRV | 31 | O15229 | |
| YGVEAFSDILRREIQ | 181 | O14756 | |
| EEFSRRYLQQLESEI | 411 | Q8WXF7 | |
| EEDRIVTQNRVFAYL | 186 | Q8NHQ1 | |
| DEARYLRIFQNVDLS | 146 | Q92562 | |
| VEEVVRNYTFLLRAA | 1726 | Q5JV73 | |
| FLEDAIAVTRYVLQD | 731 | Q6P158 | |
| EELIAYLRDESEFRD | 566 | P06756 | |
| EVLRVYYDRLLDNTD | 2211 | Q8WXX0 | |
| VRALYEETEQLREQS | 211 | Q8N4Y2 | |
| FVELSEAYRVLSREQ | 76 | Q9NNZ3 | |
| DDEVRDRATFYLNVL | 521 | Q9UBF2 | |
| EVDEVYFTLTRVDRS | 16 | P0C7T7 | |
| SAEIFRQIAEAYDVL | 41 | P59910 | |
| NIDFAEEVYTRVVRR | 116 | Q9Y2T3 | |
| RRNEFTVLELYEGTE | 801 | Q8N766 | |
| ERYDDAIQLYDRILQ | 101 | Q15006 | |
| LRVDYVIFDNFRLDE | 211 | Q17R55 | |
| LDFRVEYRDRNVDVV | 101 | Q9UNN5 | |
| DRRLFVDGQEIAVVY | 251 | P48637 | |
| TFYRELEEDRQERSA | 31 | A0A1B0GVZ2 | |
| RRLLEDAFFREEDYI | 36 | Q14147 | |
| AEVTTDDRAYVRQLV | 921 | P53992 | |
| YREFESAIVEAARLE | 231 | Q15020 | |
| ELEELRAAFTRALEY | 441 | Q15020 | |
| VVQDRVERDYTIEDL | 1151 | Q58EX2 | |
| LFDNLRRAVDEIYVT | 106 | Q9BY12 | |
| SRRIERIYFEISETN | 4186 | P21817 | |
| ELTRVVRNADEIAEY | 726 | Q68D06 | |
| IFSEVRRIENYRVEG | 521 | P30260 | |
| RELEEEFYSLVRVED | 401 | Q92613 | |
| EFYSLVRVEDVAAEL | 406 | Q92613 | |
| QVAEDYELRLAREQA | 516 | Q8N137 | |
| YFIREFSLVDQRELE | 191 | Q70IA8 | |
| IEIVSRARELYVDDS | 131 | Q5VU65 | |
| VTVLNEYERALDVAA | 2616 | P98161 | |
| YVQELAAVRADAETR | 1476 | Q14980 | |
| QEVVRAFYDTLDAAR | 831 | Q53GL7 | |
| EFRDALVQLIEDYGE | 231 | Q9UJV8 | |
| ISNAYFTRVDRDVEV | 1371 | Q16363 | |
| VLEEAEFYNIASLVR | 151 | Q14681 | |
| RYRSDLEIIFNAIDT | 566 | O14829 | |
| EDFERLLRLSDYNVQ | 776 | Q86XP0 | |
| ELLYLDRNSIAFVEE | 281 | Q9GZU5 | |
| TVLDRFYNADIAVVE | 141 | Q99683 | |
| LLQRAYRLQEEFEAT | 271 | Q8NAN2 | |
| DDEYVRLFLEEFERI | 191 | Q8N2A8 | |
| EVFEYRQALRVAEEA | 276 | A6NKG5 | |
| DIINYTLFIRELFER | 4561 | O75445 | |
| YVARRELEIESQTEE | 276 | Q9NYH9 | |
| ASFDYLRLVVRELEQ | 111 | Q8N4B1 | |
| ERRADEEELAQQYEL | 126 | Q496J9 | |
| DLDSYVFLRVRERQE | 166 | Q9BRT9 | |
| IYEELNVFERLFLED | 2901 | Q8WXH0 | |
| YDTLDQVRNRLEEVS | 636 | P28331 | |
| FARRIYEDSDADLQL | 446 | Q06033 | |
| ELSERYLFVVDRLIA | 161 | Q8N565 | |
| NDRAVLEREVQYTLE | 251 | P49354 | |
| YAVILAFDVRIERDA | 1031 | O60841 | |
| ELLFYREVSEDRRQD | 2456 | P58107 | |
| FYREVSEDRRQDLLS | 3526 | P58107 | |
| ELLFYREVSEDRRQD | 4591 | P58107 | |
| DEQARTDYFIRTLLL | 166 | Q05209 | |
| RVLFLRYVVQTLEDD | 566 | Q8NDZ2 | |
| ERIVFDILANYLSEE | 1556 | Q13796 | |
| SRIDDYDIVVRLNSA | 176 | Q11203 | |
| ISEEEAAQYDRQIRL | 11 | Q9UBE0 | |
| EFLDIARRTYTEIVD | 496 | O15457 | |
| NREYVRVFDVTERTA | 201 | Q9NRC8 | |
| IEVSREEIFEESYRQ | 401 | Q9HCE7 | |
| LENYVRSIENERDTL | 746 | Q8TBZ0 | |
| FLDAIDRREDTFYVV | 581 | Q99941 | |
| ARAELERTYQEIQEL | 341 | Q8IZ52 | |
| SYEELVRRNVELFIA | 466 | Q6IBW4 | |
| YRADDANVVRDRDLE | 1216 | P02452 | |
| FTADEARDLIQRYLT | 1101 | Q6P2Q9 | |
| EVSREEIFEESYRQV | 396 | Q9HAU4 | |
| FLVRTLVEEITEEQY | 526 | Q8N1K5 | |
| AFEVTLSRYQREAEQ | 196 | Q9NNX1 | |
| FYRDIISIAEDEDLR | 216 | P12956 | |
| EEELANLRASQREYE | 336 | Q86UC2 | |
| QREYEELRNSERAEV | 346 | Q86UC2 | |
| VRDYLEERLEAEFGQ | 326 | Q96I15 | |
| RALFVRLTQRYQEDE | 666 | P61129 | |
| RSRFINDAYQEVLDL | 1271 | Q96RL7 | |
| FYEELEALVRARTAI | 401 | P17040 | |
| LRFLNVTEERFEYVE | 321 | Q8NB66 | |
| TSLEDFYLDEERTVR | 226 | P36955 | |
| ARNVFYELEDVRDIQ | 236 | Q9C0H9 | |
| YELEDVRDIQDRSII | 241 | Q9C0H9 | |
| ETRFEVAQVESLRYR | 1211 | P12270 | |
| RASYLEIYQEEIRDL | 141 | O15066 | |
| IFRNVEVLIYVFDVE | 81 | Q7L523 | |
| FSVEYEQEAERLLVG | 206 | X6R8R1 | |
| ELALDRAEYVIESAR | 6 | Q8NEM7 | |
| YSRADEVVLARDIER | 216 | Q6P2H8 | |
| YDVQDRFRIELSEEG | 106 | O75425 | |
| IERTDEESFIVFSYR | 196 | Q9Y6L7 | |
| RDDIYVFEININRTE | 546 | Q9Y4E8 | |
| AYEEVVDQLETLRRE | 1491 | Q9UKX3 | |
| QREEDYARIVAASEA | 1141 | Q9H254 | |
| QIRLALERDVSEDYE | 56 | Q9Y6S9 | |
| TAAYEERVRALEDLA | 471 | P11277 | |
| ARQEELYSELQARET | 3356 | Q15149 | |
| VVVYRRNCRDFDTDI | 396 | Q8IZJ1 | |
| TDITQFRQLYLDDIR | 771 | O95427 | |
| LVEEEFGQRRQDLYS | 236 | O43290 | |
| YREFREEESLVEQFV | 1086 | P78527 | |
| EREFENLYIENLELR | 66 | Q9Y2I8 | |
| EIDTLQEVRLRFLSY | 86 | A6NK53 | |
| LDLEEFSRYLQEREQ | 66 | Q9BV35 | |
| ESVDYRRLARFDVIL | 266 | Q6R2W3 | |
| EEREQRALYAAILEY | 231 | Q9Y2B5 | |
| ELANEYETRAVELFT | 616 | Q7Z2W7 | |
| EEQPYFRETRAVSDV | 76 | Q9Y2D9 | |
| RRLFTEALYEEAVSQ | 221 | Q6GMV2 | |
| FLVVGDVYRRDQIDS | 171 | O95363 | |
| DVEIVEEYFARQISS | 1086 | Q5T4S7 | |
| RDDIFVYEVSGRIEA | 566 | P51784 | |
| SEVLDELYRATREFT | 36 | Q8WVP5 | |
| LTQADRLALYDFVVE | 156 | Q6IEG0 | |
| DRAVYENELVATRDV | 251 | Q12836 | |
| ELVETERDYVRDLGY | 1976 | O75962 | |
| ELIERYLNRFSSELE | 76 | Q96EY4 | |
| REEYAAIEDLFSAIN | 256 | A8MPX8 | |
| ELDREREERNYFQLE | 41 | O95995 | |
| ARTLFYVESLEEEVV | 116 | Q9NR64 | |
| YTDVFLDVIRRADLN | 1401 | O75096 | |
| FNEDVEEVTYRALRN | 311 | Q9UHQ1 | |
| ATLDLEDVRSYRAEI | 271 | Q6IA69 | |
| LREFQEGSREYEAEL | 36 | Q9NXR1 |